Skip to main content
. 2000 Jun;130(3):539–548. doi: 10.1038/sj.bjp.0703357

Figure 8.

Figure 8

Effect of SB-269970-A on sleep stage distribution during the normal sleep phase. Vehicle or SB-269970-A (30 mg kg−1) were dosed intraperitoneally at the beginning of the sleep phase (1800 h). Data are percentage time spent in each sleep phase for each of the remaining 9 h during the awake period.